Dayoung Jung | OMICS International

Journal of Oncology Research and Treatment
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Dayoung Jung

The University of Texas MD Anderson Cancer Centre, 1515 Holcombe Blvd, Houston, TX, 77030

An Update on Minimal Residual Disease(MRD) Assessment in Mantle Cell Lymphoma(MCL): A Mini Review

The field of minimal residual disease in most B-cell malignancies is critical. This is especially true for mantle cell lymphoma, a rare but aggressive subtype of non-Hodgkin’s lymphoma. A recent review of available minimal residual disease assessment methods has shown promising results in mantle cell lymphoma, specifically in the advancement ... Read More»

Dayoung Jung

: J Oncol Res Treat


Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article